Core Viewpoint - PACS Group, Inc. is facing a class action lawsuit due to allegations of fraudulent practices related to its operations in skilled nursing facilities, which has resulted in significant stock price declines and investor losses [1][3][4]. Group 1: Legal Actions - A class action has been initiated for investors who purchased PACS Group securities between April 11, 2024, and November 5, 2024, with a deadline for filing a lead plaintiff motion set for January 13, 2025 [1]. - Investors are encouraged to contact the Portnoy Law Firm for a complimentary case evaluation and to discuss options for recovering losses [2]. Group 2: Allegations Against PACS Group - Hindenburg Research published a report on November 4, 2024, accusing PACS Group of engaging in fraudulent practices as part of a turnaround strategy for underperforming skilled nursing facilities [3]. - The report claims PACS exploited taxpayer-funded healthcare programs, misused COVID-era waivers, improperly billed Medicare for unnecessary therapies, and employed unlicensed administrators [3]. Group 3: Financial Impact - Following the release of the Hindenburg report, PACS Group's stock price fell by $11.93, or 27.8%, closing at $31.01 per share, leading to substantial losses for investors [4].
PACS Group, Inc. Investors: Please contact the Portnoy Law Firm to recover your losses. January 13, 2025 Deadline to file Lead Plaintiff Motion.